(Q40929333)

24 September 2017

Immune effects of 5-fluorouracil: Ambivalence matters (English)

1 reference

24 September 2017

1 reference

3

1 reference

24 September 2017

François Ghiringhelli

series ordinal

1

object named as

François Ghiringhelli

0 references

author name string

François Ghiringhelli

series ordinal

1

1 reference

24 September 2017

Melanie Bruchard

series ordinal

2

1 reference

24 September 2017

1 March 2013

1 reference

24 September 2017

1 reference

24 September 2017

2

1 reference

24 September 2017

3

1 reference

24 September 2017

e23139

1 reference

Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661151

Predominant requirement of Bax for apoptosis in HCT116 cells is determined by Mcl-1's inhibitory effect on Bak.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661151

Why not treat human cancer with interleukin-1 blockade?

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661151

5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661151

NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661151

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661151

IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661151

Immunogenicity of anthracyclines: moving towards more personalized medicine

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661151

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661151

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

25 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FONCI.23139

21 January 2018

Identifiers

DOI

10.4161/ONCI.23139

1 reference

24 September 2017

1 reference

24 September 2017

PubMed publication ID

23802066

1 reference